QQQ   416.86 (-1.55%)
AAPL   165.06 (-1.19%)
MSFT   399.22 (-1.25%)
META   482.94 (-3.76%)
GOOGL   153.46 (-1.63%)
AMZN   174.74 (-2.50%)
TSLA   148.86 (-0.71%)
NVDA   809.73 (-4.37%)
AMD   148.29 (-4.38%)
NIO   3.82 (-4.50%)
BABA   68.65 (-0.33%)
T   16.37 (+0.24%)
F   12.11 (+0.41%)
MU   107.40 (-4.05%)
GE   148.66 (-2.80%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.29 (+12.67%)
PFE   25.79 (+1.58%)
PYPL   62.13 (+0.05%)
XOM   120.02 (+1.27%)
QQQ   416.86 (-1.55%)
AAPL   165.06 (-1.19%)
MSFT   399.22 (-1.25%)
META   482.94 (-3.76%)
GOOGL   153.46 (-1.63%)
AMZN   174.74 (-2.50%)
TSLA   148.86 (-0.71%)
NVDA   809.73 (-4.37%)
AMD   148.29 (-4.38%)
NIO   3.82 (-4.50%)
BABA   68.65 (-0.33%)
T   16.37 (+0.24%)
F   12.11 (+0.41%)
MU   107.40 (-4.05%)
GE   148.66 (-2.80%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.29 (+12.67%)
PFE   25.79 (+1.58%)
PYPL   62.13 (+0.05%)
XOM   120.02 (+1.27%)
QQQ   416.86 (-1.55%)
AAPL   165.06 (-1.19%)
MSFT   399.22 (-1.25%)
META   482.94 (-3.76%)
GOOGL   153.46 (-1.63%)
AMZN   174.74 (-2.50%)
TSLA   148.86 (-0.71%)
NVDA   809.73 (-4.37%)
AMD   148.29 (-4.38%)
NIO   3.82 (-4.50%)
BABA   68.65 (-0.33%)
T   16.37 (+0.24%)
F   12.11 (+0.41%)
MU   107.40 (-4.05%)
GE   148.66 (-2.80%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.29 (+12.67%)
PFE   25.79 (+1.58%)
PYPL   62.13 (+0.05%)
XOM   120.02 (+1.27%)
QQQ   416.86 (-1.55%)
AAPL   165.06 (-1.19%)
MSFT   399.22 (-1.25%)
META   482.94 (-3.76%)
GOOGL   153.46 (-1.63%)
AMZN   174.74 (-2.50%)
TSLA   148.86 (-0.71%)
NVDA   809.73 (-4.37%)
AMD   148.29 (-4.38%)
NIO   3.82 (-4.50%)
BABA   68.65 (-0.33%)
T   16.37 (+0.24%)
F   12.11 (+0.41%)
MU   107.40 (-4.05%)
GE   148.66 (-2.80%)
CGC   8.13 (+3.83%)
DIS   112.07 (-0.32%)
AMC   3.29 (+12.67%)
PFE   25.79 (+1.58%)
PYPL   62.13 (+0.05%)
XOM   120.02 (+1.27%)
Free Trial
NASDAQ:APEN

Apollo Endosurgery (APEN) Stock Price, News & Analysis

→ Urgent alert: open this for a huge profit potential (From Timothy Sykes) (Ad)
Free APEN Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$9.87
▼
$10.00
52-Week Range
N/A
Volume
1.66 million shs
Average Volume
1.43 million shs
Market Capitalization
$579.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
APEN stock logo

About Apollo Endosurgery Stock (NASDAQ:APEN)

Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.

APEN Stock News Headlines

February 1, 2024 | morningstar.com
Apollo Pipes Ltd 531761
November 12, 2023 | nypost.com
Astronaut Frank Borman, commander of the first Apollo mission to the moon, dead at 95
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
November 5, 2023 | cnn.com
Apollo astronaut Ken Mattingly, who helped save the crew of Apollo 13, has died
May 10, 2023 | marketwatch.com
Gastric Band and Gastric Balloon Market to Witness Growth Acceleration | Apollo Endosurgery, Cousin Surgery, Spatz FGIA Inc
April 1, 2023 | finance.yahoo.com
Apollo Endosurgery Full Year 2022 Earnings: Revenues Beat Expectations, EPS Lags
March 29, 2023 | seekingalpha.com
APEN Apollo Endosurgery, Inc.
March 7, 2023 | finance.yahoo.com
Does This Valuation Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Imply Investors Are Overpaying?
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
February 2, 2023 | benzinga.com
SHAREHOLDER ALERT: Morris Kandinov Investigating ALBO, APEN, ATCX and PAYA Mergers and Acquisitions; Shareholders are Encouraged to Contact the Firm
January 11, 2023 | benzinga.com
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Apollo Endosurgery, Inc. (APEN)
December 15, 2022 | apnews.com
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Investigating the Merger – SAL, VVNT, APEN, GRAY
December 13, 2022 | finance.yahoo.com
Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with Obesity
December 8, 2022 | msn.com
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,400 Today
December 5, 2022 | wsj.com
SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Apollo Endosurgery, Inc. - APEN
November 30, 2022 | bizjournals.com
Boston Scientific shells out $615M for gastro device firm
November 29, 2022 | nasdaq.com
Boston Scientific to buy Apollo Endosurgery for $417 million
November 29, 2022 | reuters.com
Boston Scientific to acquire Apollo Endosurgery in $615 mln deal
November 29, 2022 | finance.yahoo.com
Apollo Endosurgery to be Acquired by Boston Scientific
November 29, 2022 | finance.yahoo.com
Boston Scientific to acquire Apollo Endosurgery for $615 million in cash
November 21, 2022 | finance.yahoo.com
Apollo Endosurgery Completes Transition to European MDR Requirements for the OverStitch Systems, BIB and Orbera 365 intragastric balloons, and OverTube.
November 8, 2022 | finance.yahoo.com
Apollo Endosurgery, Inc. (NASDAQ:APEN) is largely controlled by institutional shareholders who own 58% of the company
November 7, 2022 | finance.yahoo.com
Apollo Endosurgery to Participate in Upcoming Investor Conferences
November 1, 2022 | finance.yahoo.com
Apollo Endosurgery, Inc. Reports Record $19.6 million Global Revenue in Third Quarter 2022
October 18, 2022 | finance.yahoo.com
Apollo Endosurgery to Report Third Quarter Results on November 1, 2022
October 12, 2022 | nasdaq.com
Investors in Apollo Endosurgery (NASDAQ:APEN) have made a favorable return of 92% over the past three years
October 10, 2022 | msn.com
Short Volatility Alert: Apollo Endosurgery, Inc.
See More Headlines
Receive APEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Endosurgery and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/31/2021
Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:APEN
CUSIP
N/A
CIK
1251769
Web
www.apolloendo.com
Phone
(512) 279-5100
Fax
858-678-0900
Employees
202
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($1.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-39,840,000.00
Net Margins
-51.84%
Pretax Margin
-51.08%
Return on Equity
-89.48%
Return on Assets
-33.76%

Debt

Debt-to-Equity Ratio
1.04
Current Ratio
2.35
Quick Ratio
1.89

Sales & Book Value

Annual Sales
$76.86 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.69 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
57,972,000
Free Float
47,943,000
Market Cap
$579.72 million
Optionable
Not Optionable
Beta
2.31
10 Best Cheap Stocks to Buy Now Cover
10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Key Competitors

View All Competitors

APEN Stock Analysis - Frequently Asked Questions

How were Apollo Endosurgery's earnings last quarter?

Apollo Endosurgery, Inc. (NASDAQ:APEN) released its quarterly earnings results on Sunday, October, 31st. The biotechnology company reported ($0.23) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.28) by $0.05. The biotechnology company had revenue of $16.35 million for the quarter, compared to the consensus estimate of $16.20 million. Apollo Endosurgery had a negative net margin of 51.84% and a negative trailing twelve-month return on equity of 89.48%. During the same quarter in the prior year, the firm earned ($0.11) earnings per share.

What other stocks do shareholders of Apollo Endosurgery own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Endosurgery investors own include Obalon Therapeutics (OBLN), Novavax (NVAX), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), OPKO Health (OPK), Pfizer (PFE), Sunesis Pharmaceuticals (SNSS), Biocept (BIOC), Co-Diagnostics (CODX) and Second Sight Medical Products (EYES).

This page (NASDAQ:APEN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The “Perfect Storm” for Gold
Gold Safe Exchange
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
He Is Giving Away Bitcoin
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends